Filter
329
Filtered Results: 329
Text search:
pharmacotherapy
Featured
Recommendations
29
New Publications
55
Language
Document type
No document type
186
Guidelines
65
Studies & Reports
49
Manuals
12
Training Material
5
Strategic & Response Plan
5
Fact sheets
5
Resource Platforms
2
Countries / Regions
India
20
Global
13
Ethiopia
13
Western and Central Europe
9
South Africa
9
Latin America and the Carribbean
8
Kenya
7
Eastern Europe
6
Chile
4
Indonesia
4
Ukraine
3
Rwanda
3
Nigeria
3
Burkina Faso
3
Philippines
3
Africa
3
South–East Asia Region
3
Uganda
3
Russia
3
Eswatini/ Swaziland
3
Sierra Leone
2
Cameroon
2
Estonia
2
Malawi
2
USA
2
Germany
2
Paraguay
2
Brazil
2
Botswana
2
North Macedonia
1
Nepal
1
Mexico
1
Benin
1
Canada
1
Cambodia
1
Asia
1
Jamaica
1
United Kingdom
1
Chad
1
South Sudan
1
Liberia
1
Myanmar / Burma
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
85
Clinical Guidelines
38
Public Health
32
Women & Child Health
5
Key Resources
4
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
Mental Health
118
NCDs
34
Pharmacy
29
HIV
14
NTDs
8
TB
7
AMR
7
Caregiver
5
COVID-19
4
Refugee
3
Rapid Response
2
Ebola & Marburg
2
Conflict
2
Disability
1
Planetary Health
1
Global Health Education
1
Indian J Psychiatry. 2017 Jan; 59(Suppl 1): S67–S73.
doi: 10.4103/0019-5545.196975: 10.4103/0019-5545.196975
Отчет оценочной
миссии
Январь 2014 г
An Evidence-Based Treatment Guide for Clinicians
Introduction
Chapter A.7
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Биполярное расстройство в детском возрасте
Клинический случай
Post-Traumatic Stress Disorder (PTSD) in Children under Age 6 | Post-Traumatic Stress Disorder (PTSD) in Children and Adolescents Ages 6 to 17 Years Old
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit metho...
Биполярное расстройство, известное так же, как маниакально-депрессивный психоз, является психическим заболеванием, которое характеризуется нетипичной сменой нас...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Представлены литературные данные о полиморфизме психических расстройств в периоде перименопаузы у женщин и о теориях возникновения климактерического синдрома. �...
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
[Updated 2015]
SCOPING QUESTION: What is the effectiveness of psychosocial interventions (including caregiver skills training) for behavioural disorders in children and adolescents?
Целью этой главы является представление ключевых элементов, касающихся терапевтического использования психотропных лекарственных средств у детей и подростков, �...
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
[Updated 2015]
Scoping question: What is the effectiveness of psychosocial interventions, including caregiver skills training, for emotional disorders in children and adolescents?
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
